Head and Neck Cancer Human Epiglottis Tissue Genomic DNA, Donor 115 (CAT#: DBFF-0624-HY2450)

Datasheet

Overview

Head and neck cancer refers to the abnormal proliferation of cells in the head and neck to form tumors that affect the normal function and shape of normal tissue. Head and Neck Cancer Human Epiglottis Tissue Genomic DNA, Donor 115 is a highly pure intact high molecular size DNA. It is extracted from epiglottis tissue of head and neck cancer human donor and treated with DNase-free RNase to remove contaminant RNA. Its purity and intactness make it an ideal choice for researchers seeking reliable and accurate data in their genetic research.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Female

Age At Sampling

76 yrs

Race

White or Caucasian

Medical Diagnosis

Carcinoma of epiglottis, squamous cell, metastatic

Product Description

Species

Human

Tissue Name

Epiglottis

Sample Diagnosis Category

Head and Neck Cancer

28S/18S Ratio

1.96

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Southern blot analysis, polymerase chain reaction amplification, genomic DNA methylation, single nucleotide polymorphism analysis, profiling studies in gene expression, and DNA library construction.

Product Properties

Metastatic Site

Lung

Normal Ratio

Lesional Ratio

Tumor Ratio

50%

Hypocellular/Acellular Tumor Stroma Ratio

10%

Hypercellular Tumor Stroma Ratio

40%

Necrosis Ratio

H&E Staining Pathological Verification

Hypercellular tumor stroma: desmoplasia; Hypocellular tumor stroma: dense fibrosis

Histopathological Grade

AJCC G2: Moderately differentiated

Tumor Stage

Primary Tumor (T)

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use